and an MBA from Rutgers University. Collectively, through integration of pharmacology with modeling and other quantitative methods, the functions within pharmacometrics play a central role in dose selection from first-in-human studies through global market applications as well as post-approval activities. ein Mensch und keine Maschine sind. Prior to his time at MSK,Dr. Thompsonmade significant contributions to cancer research as a physician and clinical investigator. Gang Chen, Ph.D., is the head of protein expression sciences (PES) in his role as senior vice president. Mr. Yocums broad knowledge and expertise in Good Manufacturing Practices (GMP) and processes have contributed to the successful launch of every Regeneron commercial product. Ci Brown and Goldstein jointly received the Nobel Prize for Physiology or Medicine in 1985 and the U.S. National Medal of Science in 1988. Senior Vice President, Therapeutic Proteins. in Science from the University of California, Davis. Dr. Zoghbi is the director of the Jan and Dan Duncan Neurological Research Institute at Texas Childrens Hospital, and is a Howard Hughes Medical Institute investigator. Dr. Braunstein received his B.S. Senior Vice President, Commercial Scale Manufacturing and Manufacturing Technology. A certified DE&I professional, Ms. Pillai received her BBA from KS School of Management and her MBA from Symbiosis International Business School, India. at New York Medical College and a Ph.D. from Saint Johns University. Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. in chemistry from Penn State University and his MBA from Michigan State University. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. The average Regeneron hourly pay ranges from approximately $24 per hour for an Intern - Hourly to $148 per hour for a Director. from Douglass College of Rutgers University and a Ph.D. from the University of North Carolina at Chapel Hill. Previously, Dr. Geba worked at Sanofi, AstraZeneca, Novartis, Merck and Yale University as an assistant professor of medicine. from the University of Wisconsin-Madison and his Ph.D. from the University of Washington. She is a former executive-in-residence in the Department of Management and Human Resources and former dean and John W. Berry, Sr. Senior Vice President, Associate General Counsel. Executive Vice President, Global Clinical Development. and MBA from Iona College. Se continui a visualizzare Omni Hotels & Resorts - Hot Springs He also is a member of the boards of trustees of The Rockefeller University and the Howard Hughes Medical Institute. Senior Vice President, CMC Regulatory Sciences and Industrial Affairs. Copyright 2023 Regeneron Pharmaceuticals Inc. All rights reserved. She was previously executive vice president, chief human resources ocer at Inova Health System. enviando un correo electrnico a Als u dit bericht blijft zien, stuur dan een e-mail Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. The estimated additional pay is $212,201 per year. How much do Regeneron employees make? Aris Baras, M.D., joined Regeneron in 2011 and helped found the Regeneron Genetics Center (RGC), where he now serves as senior vice president. For its 2021 fiscal year, REGENERON PHARMACEUTICALS, INC., listed the following CEO pay ratio data on its annual proxy statement to the SEC. Prior to joining Regeneron, Dr. Macdonald worked for Cadus Pharmaceuticals after completing a post-doctoral fellowship at Columbia University. The site you are about to visit is maintained by a third party who is solely responsible for its content. Anyone wants to share the salary range for VP at the pharma and biotech? Before joining the pharmaceutical industry, Dr. Hughes worked as a medical practitioner in the UK and U.S. Dr. Hughes earned a medical degree (MBBS) from The Royal Free Hospital and School of Medicine, London University, and an M.Sc. Help ons Glassdoor te beschermen door te verifiren of u een persoon bent. Prior to joining Regeneron, Mr. Austin worked for 14 years at Amgen in various roles of increasing responsibility, including assisting in starting operations at the companys Longmont, Colorado, and Juncos, Puerto Rico sites, and spent time working at both Novartis and Abbott Laboratories. CA. Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. Prior to joining Johnson & Johnson, Ms. Poon held senior leadership positions at Bristol-Myers Squibb Company, including president of international medicines and president of medical devices. Prior to Regeneron, Dr. Akinlade held medical director roles of increasing seniority at Astellas Pharma and Abbott Laboratories (now AbbVie). CA. Average salary for AstraZeneca Vice President Finance in Seaham, England: [salary]. from the University of Rochester and a Ph.D. from State University of New York. This recognition is possible thanks to our dedicated colleagues, cutting-edge work and a culture that promotes limitless possibilities. from Northwestern University. Lori Morton, Ph.D., joined Regeneron in 2002 and serves as senior vice president, research. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. He also previously served within the internal audit teams at Phillip Morris, General Foods and Bowater, Inc. Mr. Calabro received a B.S. She has been the chair of the Department of Molecular Biology and the Squibb Professor in Molecular Biology at Princeton University since 2003 and is a Howard Hughes Medical Institute investigator. He has served as the president and chief executive officer of Cerevel Therapeutics Holdings, Inc., the parent entity of Cerevel Therapeutics, Inc. since 2019, and as chair of Cerevel Therapeutics Holdings, Inc. since 2018. Ms. Ravetti leads the Global Pharmaceutical Legal Operations team, a multidisciplinary team providing legal advice on the clinical development and commercialization of Regenerons products,including advice on R&D, regulatory matters, market access, product launches, lifecycle planning, and healthcare law compliance. Between 2004 and 2006, Mr. Van Plew held positions of increasing responsibility at Chiron Biopharmaceuticals, most recently as senior director, Vacaville operations. in microbiology from Rutgers University and his Ph.D. in pharmacology/toxicology jointly from Rutgers and the University of Medicine and Dentistry of New Jersey, and has been board-certified in toxicology. He previously held roles on the tax teams at Arthur Anderson, Ernst & Young, and Diageo, and he currently serves as secretary and member of the board of trustees at Intensive Therapeutics, a 501c3 non-profit organization that provides therapy services to children with special needs. real person. He trained in internal medicine at Harvard Medical Schools Brigham Hospital and Bostons University Hospital. Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de Ned Braunstein, M.D., joined Regeneron in 2009, and serves as executive vice president, regulatory affairs and global patient safety. Mr. Austin leads a team responsible for Raheen quality control laboratory and contract laboratories functions. Prior to Regeneron, Mr. Carreau worked at Novartis (formerly Chiron Corporation). Mr. Husseini received his undergraduate degree in molecular biology from Princeton University and MBA from the Wharton School at University of Pennsylvania. Senior Vice President, Translational and Clinical Sciences, Oncology. He received his Ph.D. in biochemistry from the University of Delaware and his MBA from the State University of New York at Albany. Dr. Lin received his M.D. from Boston College and a B.A. The highest-paying job at Regeneron is a Senior Director with a salary of $376,244 per year. He completed his post-doctoral studies at the University of Pennsylvania. David Snow joined Regeneron in 2020 and is senior vice president and global head of the Dupixent(dupilumab) franchise. The average Regeneron salary ranges from approximately $52,103 per year for a Research Assistant to $376,244 per year for a Senior Director. CA. Compensation data tools, salary structures, surveys and benchmarks. The estimated salary at Regeneron ranges from approximately $51,662 per year for Human Resources Specialist to $226,077 per year for Director. She earned a B.S. Drs. Ms. Tegan received her B.S. Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie He received his Ph.D. in medicine and molecular biology from Kings College, University of Cambridge and his M.D. Prior to joining Regeneron, Mr. Calabro spent 18 years at UST, Inc., where he held positions of increasing responsibility within internal audit, ultimately serving as director of internal. Most recently she was VP, global head of DE&I at Zendesk. from the University of Buenos Aires. GSK A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. Senior Vice President, Strategic Sourcing and Procurement. Each salary is associated with a real job position. From 2009 to 2019, Mr. Ryan served as a director of Citizens Financial Group, Inc. Dr. Schleifer founded the company in 1988 and has been a director and its president and chief executive officer since its inception. Christos Kyratsous, Ph.D., joined Regeneron in 2011 and is the senior vice president of research. Executive Vice President and General Manager, Industrial Operations and Product Supply. Salaries at Regeneron range from an average of $52,000 to $139,000 a year. VA. para nos informar sobre o problema. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Regeneron Pharmaceuticals Vice-president average salary is $-, median salary is $- with a salary range from $- to $-. She oversees global HR systems and processes and is expanding HR operations to support employees in a growing number of countries outside the U.S. In addition to managing the Human Resources Department, the Director serves as the executive staffonline to the attention of Dele Lowman Smith, Senior Vice President, 630 Dundee Road, #130 Electra Aero - Manassas In addition, he was a former director of Laboratory Corporation of America Holdings, Campus Crest Communities, Inc., CRISPR Therapeutics AG, and McKesson Corporation. Senior Vice President and Site Head, IOPS Raheen. Kerry Reinertsen, Ph.D., joined Regeneron in 2011 and serves as senior vice president of strategic alliances. Prior to that, Dr. Herman completed his residency and postdoctoral training at University of California, San Francisco and was an assistant professor there before joining industry. Gilead Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. Melissa Lozner, J.D., joined Regeneron in 2022 and serves and as senior vice president, chief compliance officer. She received her B.A. If you continue to see this Executive Vice President, Functional Genomics and Chief VelociGene Operations. The estimated additional pay is $210,764 per year. Prior to his decades at Regeneron, he managed finances at Freihofer Baking Company. As on 2021. #bestplacetowork #careers, Get started with your Free Employer Profile, average salary for a Vice President is $172,519 per year in United States, The Ultimate Job Interview Preparation Guide. We encourage you to read the privacy policy of every website you visit. Sing has extensive venture capital and leadership experience in the biotechnology sector. He is the former chief executive officer and chair of the board of Prudential Financial, Inc. and served as president and chief operating officer of Chase Manhattan Bank from 1990 to 1994. Chief Executive Officer of GanD, Inc.; Chair of Grace Science, LLC. in pharmacy from Long Island University and an MBA from the University of Phoenix. Robert Vitti, MD Vice President, Clinical Sciences Ophthalmology Alyson Berliner, MD, PhD Executive Director, Ophthalmology October 11, 2019 Robert (Bob) Vitti and Alyson Berliner sit down to discuss their motivations for studying diabetic retinopathy (DR) and how their job was to shift the mindset around the disease. Merck He leads the development of our next-generation genetic therapeutics platforms and is the head of the infectious diseases therapeutic focus area. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings. Prior to joining Regeneron, Dr. DiCioccio spent 14 years with a biotechnology start-up, after previously working with Lederle Laboratories for 14 years. Mr. Fenimore is a Certified Public Accountant in the state of New York. from Lafayette College. Pfizer The estimated total pay for a Vice President at Regeneron is $420,792 per year. He is the former chief executive officer and current chair of the board of Yumanity Therapeutics, Inc. Dr. Coles is also the former president, chief executive officer and chair of the board of Onyx Pharmaceuticals, Inc., and the former president, chief executive officer, and member of the board of directors of NPS Pharmaceuticals, Inc. In her role, Dr. Morton has led the discovery and development of a highly innovative and diverse portfolio across disease areas. Prior to his current role, he served as Regenerons vice president of financial planning, and prior to joining Regeneron, he was vice president of finance at Mojave Therapeutics, Inc. Previously, he held roles and responsibilities at Regeneron across R&D and business development. Read what they think about their salaries on our Compensation FAQ page for Regeneron. from Boston University School of Medicine. How much do Regeneron employees make? Regeneron Pharmaceuticals salaries are collected from government agencies and companies. in chemical engineering at the University of North Dakota, and his Ph.D. in biochemical engineering from Massachusetts Institute of Technology. Gilead Gonzalo Merino, Ph.D., J.D., joined Regeneron in 2013 and now serves as senior vice president and chief intellectual property counsel. This recognition is possible thanks to our dedicated colleagues, cutting-edge work and a culture that promotes limitless possibilities. Deborah Tegan joined Regeneron in 2006 and serves as senior vice president, strategic sourcing and procurement. Senior Vice President, Manufacturing and Process Sciences. He earned his B.S. He serves as the Distinguished Chair in Biomedical Sciences at the University of Texas (UT) Southwestern Medical Center, a position he has held since 1989. to let us know you're having trouble. She also held a number of roles within Novartis Oncology, including head of U.S. ethics, risk & compliance, head of global integrity & compliance, ad interim, and senior legal counsel. He received his B.S. It is especially meaningful that this award is based in part on the quality and consistency of employee reviews on Glassdoor. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex,. Patrice Gilooly joined Regeneron in 1998 and serves as senior vice president, quality assurance and operations. AstraZeneca. Zoran Berkovic joined Regeneron in 2017 and is senior vice president, financial planning & analysis, where he has grown the scope of the group and fostered a culture of accountability. Of this total $822,800 was received as a salary, $1,052,182 was received as a bonus, $3,839,805 was received in stock options, $2,559,468 was awarded as stock and $24,200 came from other types of compensation. He has held leadership roles in quality, validation, regulatory, internal manufacturing and engineering. Prior to joining Regeneron, Ms. Tegan worked at Ciba Specialty Chemicals and then as senior director/head of procurement at Purdue Pharma L.P., where she held roles of increasing responsibility.